Table 2. Univariate and multivariate Cox regression analysis of recurrence-free survival in chromophobe renal cell carcinoma patients.
MicroRNA | Univariate analysis |
Multivariate analysis |
||
---|---|---|---|---|
HR (95%CI) | P value | HR (95%CI) | P value | |
Stage (I+II vs. I+II) | 6.500 (1.578-26.77) | 0.010a | 8.388(1.505-46.74) | 0.015a |
hsa-mir-191 | 9.389 (1.169-75.43) | 0.035a | 0.968(0.086-10.89) | 0.979 |
hsa-mir-19a | 9.264 (1.157-74.20) | 0.036a | 7.057(0.636-78.31) | 0.112 |
hsa-mir-210 | 9.147 (1.143-73.22) | 0.037a | 26.01(2.423-279.1) | 0.007a |
hsa-mir-425 | 84.31 (0.372-19121) | 0.109 | 75528(0.001->1000) | 0.958 |
HR, hazard ratio; 95% CI, 95% confidential interval.
astatistical significant results (in bold).